Walker Rebecca L, Siegel Andrew W
Life Sciences Values and Society Program and Department of Philosophy, University of Michigan, Ann Arbor, MI 48109-1003, USA.
Health Econ. 2002 Apr;11(3):265-73. doi: 10.1002/hec.665.
In this paper, we consider whether there is a clear moral justification for the proposal that societal value preferences (SVPs) should be included in Cost Effectiveness Analyses (CEA) of health care resource allocations. We argue, first, that proponents of the use of SVPs need to be clear about the relationship between these values and moral principles. In particular, once moral principles are accepted as ruling out some SVPs (such as those that are irrational or revealing prejudice), an account is required of why we need to appeal to SVPs rather than moral principles to determine a just division of health care resources. Secondly, we consider whether an independent moral justification might underwrite the use of SVPs. In various places in the literature the notions of representation, presumed consent and democratic decision making appear to be invoked as candidates for fulfilling this justificatory role. We discuss some problems with each of these justifications in the hope of eliciting a more comprehensive proposal from the proponents of SVPs. We conclude that, although a number of interesting proposals have been made, no compelling justification for including SVPs in CEA has yet been systematically articulated.
在本文中,我们探讨对于将社会价值偏好(SVPs)纳入医疗资源分配的成本效益分析(CEA)这一提议,是否存在明确的道德依据。我们首先指出,主张使用社会价值偏好的人需要明确这些价值与道德原则之间的关系。特别是,一旦道德原则被认为排除了某些社会价值偏好(例如那些不合理或显示偏见的偏好),就需要说明为什么我们需要诉诸社会价值偏好而非道德原则来确定医疗资源的公正分配。其次,我们考虑是否有独立的道德依据可以支持社会价值偏好的使用。在文献的不同地方,代表性、推定同意和民主决策等概念似乎被作为履行这一辩护作用的候选依据。我们讨论了这些依据各自存在的一些问题,希望能促使社会价值偏好的支持者提出更全面的提议。我们的结论是,尽管已经提出了一些有趣的提议,但尚未有人系统地阐明将社会价值偏好纳入成本效益分析的令人信服的依据。